mark hyman glp 1 Ozempic and other GLP1 drugs have been helpful for a lot of people. But when you start prescribing them to nearly 40 million Americans, you have to expect complications and side effects Dr. Mark Hyman on Why

Jais A, Brning JC (2017) Hypothalamic inflammation in obesity and metabolic disease

If you are unable to lose weight through conventional methods like dieting and exercise, you might need to take a different approach to achieve your weight loss goals

By promoting collagen production, IV therapy improves skin elasticity and reduces the appearance of wrinkles and fine lines

Furthermore, the convenience of a once-weekly subcutaneous injection makes semaglutide an appealing option for many patients

In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) has been resolved, Dulaglutide (Trulicity) shortage resolved in June 2025

Adequate hydration supports nutrient delivery and waste removal